ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $19,093,000 | -6.4% | 1,534,851 | +3.0% | 0.01% | -10.0% |
Q3 2016 | $20,408,000 | +109.0% | 1,490,843 | +12.8% | 0.01% | +100.0% |
Q2 2016 | $9,763,000 | +20.2% | 1,321,202 | +3.9% | 0.01% | +25.0% |
Q1 2016 | $8,124,000 | +8.4% | 1,271,477 | +6.0% | 0.00% | 0.0% |
Q4 2015 | $7,497,000 | +8.1% | 1,199,668 | +1.0% | 0.00% | 0.0% |
Q3 2015 | $6,935,000 | -29.4% | 1,187,523 | +0.0% | 0.00% | -33.3% |
Q2 2015 | $9,817,000 | +5.4% | 1,187,242 | +5.0% | 0.01% | +20.0% |
Q1 2015 | $9,317,000 | +30.2% | 1,130,765 | +8.5% | 0.01% | +25.0% |
Q4 2014 | $7,158,000 | +28.6% | 1,042,014 | +1.1% | 0.00% | 0.0% |
Q3 2014 | $5,566,000 | -13.2% | 1,030,811 | +2.3% | 0.00% | 0.0% |
Q2 2014 | $6,416,000 | -11.4% | 1,007,344 | +12.1% | 0.00% | -20.0% |
Q1 2014 | $7,243,000 | +23.1% | 898,704 | +4.2% | 0.01% | +25.0% |
Q4 2013 | $5,883,000 | -60.1% | 862,680 | +7.5% | 0.00% | -66.7% |
Q3 2013 | $14,760,000 | +13.2% | 802,163 | +7.6% | 0.01% | +9.1% |
Q2 2013 | $13,036,000 | – | 745,341 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |